Variables affecting in vivo performance of high-capacity adenovirus vectors. - Wikidata - wikimedia - TriplyDB

Variables affecting in vivo performance of high-capacity adenovirus vectors.

Variables affecting in vivo performance of high-capacity adenovirus vectors.

http://www.wikidata.org/entity/Q39682415

about

The adenovirus genome contributes to the structural stability of the virion The role of chromatin in adenoviral vector function Gutless adenovirus: last-generation adenovirus for gene therapy Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels.Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).Viral hybrid vectors for somatic integration - are they the better solution?Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Stable In Vivo Transgene Expression in Endothelial Cells with Helper-Dependent Adenovirus: Roles of Promoter and Interleukin-10.Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.Gene-therapy delivery strategies in cardiology.Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system.

P2860

Q26825101-53205A53-2809-4354-98B4-A14EDF2E51B7 Q27004695-DB9338BD-4D05-4F35-949C-EFE6CB32813B Q28277560-953FCDDC-54B8-444B-9BDD-D94BA1449D4B Q34797039-FE279E7C-93AE-42AE-9DDA-49D3080CAC7A Q34977697-CA51F17C-39FB-4B51-9FC2-A01B65846943 Q35069550-CFC4B7C7-4920-4699-8036-0B9A3D3FA030 Q36344509-BEE6C800-6E4F-45D7-BFC2-781DB98B5406 Q37615161-1D2A0F4D-DAD4-45A9-A329-AA88EDCF6F2D Q37945189-1FAEC098-6CED-4996-9ECC-18C9CC23257C Q37945218-859142E0-8756-4779-B232-3052F2E31C61 Q39189210-C8CFBF78-AD9C-4C0A-9173-EE4CBA3236D9 Q39595240-EE309C8D-3A39-457F-BC05-A0A562748E64 Q40119187-55F50522-F1AB-4350-9F17-AE8D35E98F17 Q44178358-D12E6CA3-B891-4131-AA9F-81DEB59C92AB

P2860

Variables affecting in vivo performance of high-capacity adenovirus vectors.

http://www.wikidata.org/entity/Q39682415

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Variables affecting in vivo performance of high-capacity adenovirus vectors.

@en

Variables affecting in vivo performance of high-capacity adenovirus vectors.

@nl

type

label

Variables affecting in vivo performance of high-capacity adenovirus vectors.

@en

Variables affecting in vivo performance of high-capacity adenovirus vectors.

@nl

prefLabel

Variables affecting in vivo performance of high-capacity adenovirus vectors.

@en

Variables affecting in vivo performance of high-capacity adenovirus vectors.

@nl

P1433

Q39682415-45703AA5-DB6E-4F7D-8684-5A5F441174DD

P1476

Q39682415-BEE3D33D-2AB6-46F9-BF3E-EB91ADD50EC9

P2093

Q39682415-43396C99-2B51-4364-8950-9A068D5C0F64

Q39682415-7B6A62FD-4933-4BA6-9DE1-CD01A2257538

Q39682415-B06149B8-007E-4EB7-9D4C-7A4BA2A60A60

Q39682415-E1934464-ABB6-4ECD-9D88-C97CBBD007A4

Q39682415-EBE0AD10-01D1-452E-9D1B-4F012DD2385E

Q39682415-F120E277-14F9-44A2-A237-7CCB946C67EA

P2860

Q39682415-00C48B2F-651F-46DF-A07E-7D7A43C1DB9B

Q39682415-02D5802C-5944-4F12-B153-E2C84F3C3698

Q39682415-03FEC126-9401-4400-B883-6A2BE25093B3

Q39682415-05A36465-5D52-4F44-9144-159BDF74227F

Q39682415-096B4CC2-83E8-4691-9AD6-667CF20A8595

Q39682415-0D7D619B-3F50-405F-BAB1-C142AC1EFFC1

Q39682415-119427AA-7949-4180-B4A4-88F6C836FC12

Q39682415-1677E35B-90C9-482A-A5DC-6831A18916B2

Q39682415-18746BD4-B6F7-4824-B302-F12120E74F7F

Q39682415-1BA4584C-591B-431E-A814-4109234728C7

P304

Q39682415-B5930B39-2DD6-4A3B-ADE3-F9D7BDF03100

P31

Q39682415-18C936FC-AD8A-45A2-B32E-067E1CA99A5D

P356

Q39682415-E7DEF4F6-97AD-4CC4-A654-DF37B2751683

P407

Q39682415-4E4E9F6E-5CDE-4CD5-8847-5BE6ABAFE235

P433

Q39682415-F0D5F2D1-87E8-49A8-9AD5-E4C541A787C6

P478

Q39682415-A508B293-756A-44F8-B85D-A8CA2EBA2EFC

P577

Q39682415-BD79FD62-9C46-4E64-BAFE-998B77B796C1

P698

Q39682415-0BE54AA5-3D29-472F-AE50-387D1F92571E

P921

Q39682415-B188D00D-AEE6-48CF-8CB9-7E860C98B9C5

P932

Q39682415-97646F3D-B075-47BD-B489-9040950C6A96

P356

JVI.76.4.1600-1609.2002

P1433

Journal of Virology

P1476

Variables affecting in vivo performance of high-capacity adenovirus vectors.

@en

P2093

Gudrun Schiedner

http://www.w3.org/2001/XMLSchema#string

Marion Johnston

http://www.w3.org/2001/XMLSchema#string

Sabine Hertel

http://www.w3.org/2001/XMLSchema#string

Stefan Kochanek

http://www.w3.org/2001/XMLSchema#string

Volker Biermann

http://www.w3.org/2001/XMLSchema#string

Volker Dries

http://www.w3.org/2001/XMLSchema#string

P2860

Heterologous introns can enhance expression of transgenes in mice

High-capacity adenoviral vectors for gene transfer and somatic gene therapy.

Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.

Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.

Automated DNA sequencing of the human HPRT locus.

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo

Adenovirus-mediated regulable target gene expression in vivo.

Optimization of the helper-dependent adenovirus system for production and potency in vivo.

Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for ch

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

P304

1600-1609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.76.4.1600-1609.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11799154

http://www.w3.org/2001/XMLSchema#string

P921

P932

135880

http://www.w3.org/2001/XMLSchema#string